TLSA Stock Analysis: Buy, Sell, or Hold?
TLSA - Tiziana Life Sciences Ltd. Common Shares
$0.97
-0.06 (-5.89%)
▼
5d:
+6.49%
30d:
-26.01%
90d:
-27.66%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 07, 2026
2d
Get Alerted When TLSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TLSA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TLSA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TLSA is currently trading at $0.97, which is considered oversold relative to its 30-day fair value range of $0.98 to $1.25.
Technical Outlook: Technically, TLSA is in a downtrend. Immediate support is located at $0.87, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: TLSA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.02 (+830.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TLSA is in a downtrend. Immediate support is located at $0.87, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: TLSA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $9.02 (+830.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.98 -
$1.25
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.9%)
- BULLISH: Trading 830.1% below Wall St target ($9.02)
Trading Range Analysis
30-Day Trading Range
$0.98 -
$1.25
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.87
Resistance Level
$1.15
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Wall Street Target
$9.02
(+830.1%)
Share & Embed Analysis
Last updated: August 04, 2026 1:34 AM ET
Data refreshes hourly during market hours. Next update: 2:34 AM
Data refreshes hourly during market hours. Next update: 2:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 60 HOLD |
